NHS England

Company

Last mentioned: 2d ago

Timeline

  1. MHRA Intervention

    The UK medicines regulator issues a formal pause on the trial due to newly identified concerns.

  2. Clinical Trial Launch

    NHS England begins the formal clinical trial to gather data on the effects of puberty blockers.

  3. Cass Review Published

    Final report recommends that puberty blockers only be administered within a research framework.

Stories mentioning NHS England 1

Clinical Trials Bearish

MHRA Halts UK Puberty Blocker Clinical Trial Amid Safety Concerns

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has suspended a pivotal clinical trial investigating the use of puberty blockers for children. The pause follows the emergence of new regulatory concerns, effectively halting the primary research pathway for gender-affirming care in the UK.

9 sources